Navigation Links
Codexis Names Wes Bolsen VP and Chief Marketing Officer
Date:12/5/2011

REDWOOD CITY, Calif., Dec. 5, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced Wesley J. Bolsen has been named Vice President and Chief Marketing Officer.  In this new position, Mr. Bolsen will have responsibility for the company's corporate marketing and communications.  He will report to Alan Shaw, Ph.D., President and Chief Executive Officer.

Mr. Bolsen is a widely recognized marketing executive in the global biofuels industry. He joins Codexis from Coskata, where he most recently served as Chief Marketing Officer. While at Coskata from 2007-2011, he also held the senior management positions of Vice President, Government Affairs and Vice President, Business Development.  Previously, he was Chief Financial Officer for ICM, Inc., and a Senior Consultant for McKinsey & Co.

He was named the Top CMO in the United States in 2011 by the Chief Marketing Officer Institute, and is an executive board member of the Renewable Fuels Association, a former board member of the Advanced Biofuels Association and a founding member of the Advanced Ethanol Council. Mr. Bolsen holds a bachelor's degree in electrical engineering from Rose Hulman Institute of Technology and an MBA from the Stanford Graduate School of Business.

"We are very pleased to welcome Wes Bolsen to Codexis," Dr. Shaw said.  "His active leadership role as an advocate in the biofuels industry, combined with his proven expertise in marketing, will be important as Codexis moves towards commercialization of renewable fuels and chemicals products."

Codexis is an industrial biotechnology company producing high value sustainable chemicals, clean fuels, cost effective pharmaceutical processes and renewable bioindustrial ingredients to make industry more efficient, productive and profitable.  Partners include global leaders such as Shell, Merck and Pfizer.  For more information, see www.codexis.com.

 

Contacts:
Media:  Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771; Investors:  Henk Adriaenssens, ir@codexis.com, 650.421.8331

 


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shell Transfers Its Codexis Shares to Raizen
2. Codexis Reports First Quarter 2011 Results
3. Former Senator Byron Dorgan Elected to Codexis Board
4. Codexis Reports Fourth Quarter and Full Year 2010 Results
5. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
6. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
7. Codexis R&D Productivity Panels Also Used By Roche
8. Codexis Names Lori Giver VP Systems Biology
9. Codexis, Teva in Licensing Agreement Final
10. Codexis Names Vice President, Intellectual Property
11. Codexis, Arch Announce Expanded Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Oakland, California (PRWEB) , ... March 28, 2017 , ... ... that its flagship product, AllegroGraph , has been named a ‘Champion’ by Bloor ... “AllegroGraph is the highest ranked product in its class, and, thanks to Gruff, it ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017  (AACR17, Booth ... sequencing during the American Association for Cancer Research (AACR) ... in Washington, D.C. , April 1-5, ... expression of thousands of cells at the individual level. ... Experts on-hand at AACR to discuss expanded next ...
(Date:3/28/2017)... HOLLISTON, Mass. , March 28, 2017 ... "Company"), a biotechnology company developing bioengineered organ implants to ... bronchus and trachea, today announced that Jim McGorry, ... 3D Printing and BioEngineering panel at the ... 2017 at 2:30 PM ET in Cambrige, Massachussetts. The ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
Breaking Biology Technology:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):